AU2242197A - Benzimidzolyl neuropeptide y receptor antagonists - Google Patents
Benzimidzolyl neuropeptide y receptor antagonistsInfo
- Publication number
- AU2242197A AU2242197A AU22421/97A AU2242197A AU2242197A AU 2242197 A AU2242197 A AU 2242197A AU 22421/97 A AU22421/97 A AU 22421/97A AU 2242197 A AU2242197 A AU 2242197A AU 2242197 A AU2242197 A AU 2242197A
- Authority
- AU
- Australia
- Prior art keywords
- benzimidzolyl
- neuropeptide
- receptor antagonists
- antagonists
- receptor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/12—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9600344 | 1996-01-09 | ||
| GBGB9600344.7A GB9600344D0 (en) | 1996-01-09 | 1996-01-09 | Benzimidzolyl neuropeptide y receptor antagonists |
| US2163696P | 1996-07-12 | 1996-07-12 | |
| US021636 | 1996-07-12 | ||
| PCT/US1997/000511 WO1997025041A1 (fr) | 1996-01-09 | 1997-01-09 | Antagonistes benzimidazolyles du recepteur du neuropeptide y |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2242197A true AU2242197A (en) | 1997-08-01 |
Family
ID=26308442
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU22421/97A Abandoned AU2242197A (en) | 1996-01-09 | 1997-01-09 | Benzimidzolyl neuropeptide y receptor antagonists |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP0871442A1 (fr) |
| JP (1) | JP2000501107A (fr) |
| AU (1) | AU2242197A (fr) |
| CA (1) | CA2242579A1 (fr) |
| WO (1) | WO1997025041A1 (fr) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998040356A1 (fr) * | 1997-03-12 | 1998-09-17 | Banyu Pharmaceutical Co., Ltd. | Medicaments contenant des derives d'aminopyridine comme ingredient actif |
| DE69830409T2 (de) * | 1997-08-05 | 2006-01-26 | Pfizer Products Inc., Groton | 4-aminopyrrole[3,2-d]pyrimidine als neuropeptid rezeptor antagonisten |
| SE9703414D0 (sv) * | 1997-09-23 | 1997-09-23 | Astra Ab | New compounds |
| DE19801648A1 (de) * | 1998-01-17 | 1999-07-22 | Bayer Ag | alpha-Substituierte Lactone |
| US6187777B1 (en) | 1998-02-06 | 2001-02-13 | Amgen Inc. | Compounds and methods which modulate feeding behavior and related diseases |
| US20070004713A1 (en) * | 2000-12-07 | 2007-01-04 | Bernard Barlaam | Therapeutic benimidazole compounds |
| TW593278B (en) * | 2001-01-23 | 2004-06-21 | Wyeth Corp | 1-aryl-or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands |
| KR100657056B1 (ko) | 2002-06-05 | 2006-12-13 | 에프. 호프만-라 로슈 아게 | 중추 신경계 장애의 치료를 위한 5-ｈｔ6-수용체조절제로서 1-설폰일-4-아미노알콕시 인돌 유도체 |
| JP4806628B2 (ja) | 2003-05-05 | 2011-11-02 | プロビオドルグ エージー | グルタミニルシクラーゼ阻害剤 |
| EP2338490A3 (fr) | 2003-11-03 | 2012-06-06 | Probiodrug AG | Combinaisons utiles pour le traitement de désordres neuronales |
| BRPI0507485A (pt) | 2004-02-05 | 2007-07-10 | Probiodrug Ag | inibidores novos de glutaminil ciclase |
| CN100567270C (zh) * | 2004-02-19 | 2009-12-09 | 万有制药株式会社 | 磺酰胺衍生物 |
| US20070049593A1 (en) | 2004-02-24 | 2007-03-01 | Japan Tobacco Inc. | Tetracyclic fused heterocyclic compound and use thereof as HCV polymerase inhibitor |
| US7659263B2 (en) | 2004-11-12 | 2010-02-09 | Japan Tobacco Inc. | Thienopyrrole compound and use thereof as HCV polymerase inhibitor |
| WO2008055945A1 (fr) | 2006-11-09 | 2008-05-15 | Probiodrug Ag | Dérivés 3-hydr0xy-1,5-dihydr0-pyrr0l-2-one utiles en tant qu' inhibiteurs de la glutaminyl-cyclase dans le traitement des ulcères, du cancer et d'autres maladies |
| ATE554085T1 (de) | 2006-11-30 | 2012-05-15 | Probiodrug Ag | Neue inhibitoren von glutaminylcyclase |
| EP2117540A1 (fr) | 2007-03-01 | 2009-11-18 | Probiodrug AG | Nouvelle utilisation d'inhibiteurs de la glutaminyl cyclase |
| JP5667440B2 (ja) | 2007-04-18 | 2015-02-12 | プロビオドルグ エージー | グルタミニルシクラーゼ阻害剤としてのチオ尿素誘導体 |
| MX2011001887A (es) | 2008-08-22 | 2011-04-04 | Baxter Int | Derivados de bencil carbonato polimericos. |
| SG178953A1 (en) | 2009-09-11 | 2012-04-27 | Probiodrug Ag | Heterocylcic derivatives as inhibitors of glutaminyl cyclase |
| US9181233B2 (en) | 2010-03-03 | 2015-11-10 | Probiodrug Ag | Inhibitors of glutaminyl cyclase |
| AU2011226074B2 (en) | 2010-03-10 | 2015-01-22 | Vivoryon Therapeutics N.V. | Heterocyclic inhibitors of glutaminyl cyclase (QC, EC 2.3.2.5) |
| US8541596B2 (en) | 2010-04-21 | 2013-09-24 | Probiodrug Ag | Inhibitors |
| LT2624696T (lt) | 2010-10-06 | 2017-03-10 | Glaxosmithkline Llc | Benzimidazolo deriniai kaip pi3 kinazės inhibitoriai |
| ES2570167T3 (es) | 2011-03-16 | 2016-05-17 | Probiodrug Ag | Derivados de benzimidazol como inhibidores de glutaminil ciclasa |
| US9388140B2 (en) | 2011-03-31 | 2016-07-12 | Bayer Intellectual Property Gmbh | Substituted benzimidazoles |
| CN103965113A (zh) * | 2014-05-06 | 2014-08-06 | 四川大学 | 1-羟乙基-2-取代苯氧甲基苯并咪唑类化合物及其制备方法 |
| ES2812698T3 (es) | 2017-09-29 | 2021-03-18 | Probiodrug Ag | Inhibidores de glutaminil ciclasa |
| JP6400869B1 (ja) * | 2018-02-23 | 2018-10-03 | 日本曹達株式会社 | ４，５−ジシアノ−２−（フルオロアルキル）イミダゾールの製造方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4772703A (en) * | 1986-01-27 | 1988-09-20 | American Home Products Corporation | 2-(phenoxymethyl)-quinazolines as antiallergic and antiinflammatory agents |
-
1997
- 1997-01-09 AU AU22421/97A patent/AU2242197A/en not_active Abandoned
- 1997-01-09 WO PCT/US1997/000511 patent/WO1997025041A1/fr not_active Application Discontinuation
- 1997-01-09 EP EP97905573A patent/EP0871442A1/fr not_active Withdrawn
- 1997-01-09 JP JP9525457A patent/JP2000501107A/ja active Pending
- 1997-01-09 CA CA002242579A patent/CA2242579A1/fr not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JP2000501107A (ja) | 2000-02-02 |
| EP0871442A1 (fr) | 1998-10-21 |
| WO1997025041A1 (fr) | 1997-07-17 |
| CA2242579A1 (fr) | 1997-07-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2242197A (en) | Benzimidzolyl neuropeptide y receptor antagonists | |
| AU7079498A (en) | Neuropeptide y receptor antagonist | |
| AU3953795A (en) | Bicyclic neuropeptide y receptor antagonists | |
| AU3579897A (en) | Fibrinogen receptor antagonists | |
| AU3633997A (en) | Chemokine receptor antagonists | |
| AU4746297A (en) | Vitronectin receptor antagonists | |
| AU7692996A (en) | Receptor antagonists | |
| AU1765695A (en) | Non-peptidyl tachykinin receptor antagonists | |
| NZ318228A (en) | Indolyl neuropeptide y receptor antagonists | |
| AU1251597A (en) | Cosmetic composition containing a neuropeptide Y receptor antagonist | |
| AU3899997A (en) | Muscarinic antagonists | |
| HU9603525D0 (en) | Vironectin receptor antagonists | |
| AU5577096A (en) | Sulfonylquinolines as neuropeptide y1 antagonists | |
| HU9600663D0 (en) | Endothelin-receptor antagonists | |
| AU8689798A (en) | Integrin receptor antagonists | |
| EP0885205A4 (fr) | Antagonistes des recepteurs de fibrinogenes | |
| EP0885213A4 (fr) | Antagonistes du recepteur du fibrinogene | |
| AU1230795A (en) | Adhesion receptor antagonists | |
| AU9185598A (en) | Novel neuropeptide y receptor antagonists | |
| EP0809648A4 (fr) | Recepteur du neuropeptide y | |
| GB9523999D0 (en) | Indolyl neuropeptide y receptor antagonists | |
| AU3661895A (en) | Adhesion receptor antagonists | |
| AU1296899A (en) | Phenyl-alkyl-imidazoles as h3 receptor antagonists | |
| GB9600344D0 (en) | Benzimidzolyl neuropeptide y receptor antagonists | |
| AU4999897A (en) | Heteroaryl spiroethercycloalkyl tachykinin receptor antagonists |